UBE2F and liver cancer: Biologically, UBE2F knockdown in liver cancer cells inactivates mTORC1 to suppress cell growth, reduce cell size and induce autophagy, whereas liver-specific Ube2f deletion significantly inhibits liver steatosis and tumorigenesis induced by Pten loss.